DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2230898/why-walt-disney-dis-is-a-top-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_focus_list-2230898 Feb 23, 2024 - Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service. 0

https://www.fool.com/investing/2024/02/23/heres-why-home-depot-is-a-top-retail-stock-to-buy/?source=iedfolrf0000001 Feb 23, 2024 - Although it's facing a slowdown, this is still a high-quality business. 0

https://www.zacks.com/stock/news/2230556/barings-bdc-bbdc-tops-q4-earnings-and-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2230556 Feb 22, 2024 - Barings BDC (BBDC) delivered earnings and revenue surprises of 3.33% and 6.45%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2230555/guardant-health-gh-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2230555 Feb 22, 2024 - Guardant Health (GH) delivered earnings and revenue surprises of -69.89% and 2.20%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2230553/cs-disco-law-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2230553 Feb 22, 2024 - CS Disco (LAW) delivered earnings and revenue surprises of 90% and 2.30%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2230549/exp-world-holdings-expi-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2230549 Feb 22, 2024 - eXp World Holdings (EXPI) delivered earnings and revenue surprises of -300% and 4.09%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2230523/veracyte-vcyt-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2230523 Feb 22, 2024 - Veracyte (VCYT) delivered earnings and revenue surprises of 42.86% and 2.84%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2230510/select-medical-sem-tops-q4-earnings-and-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2230510 Feb 22, 2024 - Select Medical (SEM) delivered earnings and revenue surprises of 16.13% and 3.02%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2230519/irhythm-technologies-irtc-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2230519 Feb 22, 2024 - iRhythm Technologies (IRTC) delivered earnings and revenue surprises of -110% and 1.05%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2230518/vir-biotechnology-inc-vir-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2230518 Feb 22, 2024 - Vir Biotechnology, Inc. (VIR) delivered earnings and revenue surprises of 24.56% and 31.69%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock? 0